CoChat
Sign Up
Cited by 45

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects

Marcoux, Caroline, Tremblay, Michel, Fredenrich, Alexandre, Jacques, Hélène, Krimbou, Larbi, Nakajima, Katsuyuki, Davignon, Jean, Cohn, Jeffrey S·1998·Atherosclerosis
DOI 10.1016/s0021-9150(98)00042-2
Open this paper in CoChat — free account

Abstract

Remnant-like particle (RLP) lipid and apolipoprotein (apo) levels were determined in the plasma of normolipidemic and hyperlipidemic subjects, in order to investigate the relationship between RLP levels and the concentration of other plasma lipoprotein parameters. Plasma RLP fractions were isolated with the use of an immunoaffinity gel (RLP-Cholesterol Jimro II, Japan Immunoresearch Lab.), containing specific anti-apoB-100 and anti-apoA-I antibodies. Four groups of human subjects were selected, who had either matching or significantly different levels of plasma triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C): (1) normolipidemic control (NC) subjects (n = 10), (2) patients with elevated levels of LDL-C (type IIa, LDL-C (mean +/- S.E.), 4.65 +/- 0.09 mmol/l, n = 10), (3) hypertriglyceridemic (HTG) patients with elevated LDL-C (type IIb, TG: 3.86 +/- 0.36; LDL-C: 4.67 +/- 0.21 mmol/l, n = 10), and (4) HTG patients with normal LDL-C (type IV, TG: 3.71 +/- 0.39 mmol/l, n = 10). NC subjects (RLP-C: 0.22 +/- 0.01; RLP-TG: 0.24 +/- 0.03 mmol/l) had RLP apoB, apoC-III and apoE levels of 3.2 +/- 0.3, 1.8 +/- 0.3, and 1.4 +/- 0.1 mg/dl, representing 3.2 +/- 0.4, 14.5 +/- 1.4 and 32.1 +/- 2.1% of total plasma levels, respectively. RLP lipid and apolipoprotein concentrations were significantly higher in HTG groups (type IIb and IV) compared to NTG groups (NC and type IIa) (e.g. RLP-C: 0.50 +/- 0.07 and 0.58 +/- 0.11 vs. 0.22 +/- 0.01 and 0.21 +/- 0.01 mmol/l, respectivel…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0021-9150(98)00042-2

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 35

  1. Gianturco, 1991, Triglyceride-rich lipoproteins and their role in atherosclerosis, Curr Opin Lipidol, 2, 324, 10.1097/00041433-199110000-00009 · DOI
  2. Havel, 1994, McCollum Award Lecture, 1993: Triglyceride-rich lipoproteins and atherosclerosis—new perspectives, Am J Clin Nutr, 59, 795, 10.1093/ajcn/59.4.795 · DOI
  3. Hamsten, 1993, The hemostatic system and coronary heart disease, Thromb Res, 70, 1, 10.1016/0049-3848(93)90221-9 · DOI
  4. Nakajima, 1993, Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels, Clin Chim Acta, 223, 53, 10.1016/0009-8981(93)90062-9 · DOI
  5. Campos, 1992, Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100, J Lipid Res, 33, 369, 10.1016/S0022-2275(20)41527-5 · DOI
  6. Ikewaki K, Shige H, Nakajima K, Nakamura H. Postprandial remnant-like particles and coronary artery disease. In: Woodward FP, Davignon J, Sniderman A, editors. Atherosclerosis X. Amsterdam: Elsevier, 1995:200–202.
  7. Shimizu, 1993, An increase of serum remnant-like particles in noninsulin-dependent diabetic patients with microalbuminuria, Clin Chim Acta, 221, 191, 10.1016/0009-8981(93)90033-Z · DOI
  8. Nakajima, 1994, A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay, J Atheroscler Thromb, 1, 30, 10.5551/jat1994.1.30 · DOI
  9. Sekihara, 1996, High postprandial plasma remnant-like particles-cholesterol in patients with coronary artery diseases on chronic maintenance hemodialysis, Jpn J Nephrol, 38, 220
  10. Tanaka, 1995, Remnant-like particles and restenosis of coronary arteries after PTCA, Ann NY Acad Sci, 748, 595, 10.1111/j.1749-6632.1994.tb17369.x · DOI
  11. Tomono, 1994, Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages, J Atheroscler Thromb, 1, 98, 10.5551/jat1994.1.98 · DOI
  12. Knöfler, 1995, Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro, Thromb Res, 78, 161, 10.1016/0049-3848(95)00044-5 · DOI
  13. Fredrickson DS, Goldstein JL, Brown MS. The familial hyperlipoproteinemias. In: Stanbury MF, Wyngaarden JB, Fredrickson DS, editors. The Metabolic Basis of Inherited Diseases. New York, NY: McGraw-Hill, 1978:604–655.
  14. Cohn, 1996, Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects, Arterioscler Thromb Vasc Biol, 16, 149, 10.1161/01.ATV.16.1.149 · DOI
  15. Nakajima, 1996, Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apo B-100 and apo A-I, J Clin Ligand Assay, 19, 177
  16. Warnick, 1978, A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol, J Lipid Res, 19, 65, 10.1016/S0022-2275(20)41577-9 · DOI
  17. Hill, 1990, Improved phenotyping of apolipoprotein E: application to population frequency distribution, Clin Chem, 36, 1871, 10.1093/clinchem/36.11.1871 · DOI
  18. Fredenrich, 1997, Plasma lipoprotein distribution of apo C-III in normolipidemic and hyperlipidemic subjects: comparison of the apo C-III to apo E ratio in different lipoprotein fractions, J Lipid Res, 38, 1421, 10.1016/S0022-2275(20)37424-1 · DOI
  19. Albers, 1989, Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay as a candidate reference method for the measurement of apolipoprotein B-100, J Lipid Res, 30, 1445, 10.1016/S0022-2275(20)38265-1 · DOI
  20. Mackie, 1981, Concentration and distribution of human plasma apolipoprotein E, Clin Chim Acta, 116, 35, 10.1016/0009-8981(81)90166-2 · DOI
  21. Castro, 1984, Evidence for the distribution of apolipoprotein E between lipoprotein classes in human normocholesterolemic plasma and for the origin of unassociated apolipoprotein E (Lp-E), J Lipid Res, 25, 58, 10.1016/S0022-2275(20)37844-5 · DOI
  22. Gibson, 1983, Apolipoprotein E-enriched lipoprotein subclasses in normolipidemic subjects, J Lipid Res, 24, 886, 10.1016/S0022-2275(20)37934-7 · DOI
  23. Schonfeld, 1979, Apolipoprotein C-II and C-III levels in hyperlipoproteinemia, Metabolism, 28, 1001, 10.1016/0026-0495(79)90004-0 · DOI
  24. Rubinsztein, 1990, Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects, J Clin Invest, 86, 1306, 10.1172/JCI114839 · DOI · Paper page
  25. Cohn, 1997, Prevalence of double pre-beta lipoproteinemia in hyperlipidemic patients is influenced by gender, menopausal status and apo E phenotype, Arterioscler Thromb Vasc Biol, 17, 2630, 10.1161/01.ATV.17.11.2630 · DOI
  26. Bijvoet, 1996, Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency, J Lipid Res, 37, 640, 10.1016/S0022-2275(20)37605-7 · DOI
  27. Nestel, 1982, Increased lipoprotein-remnant formation in chronic renal failure, New Engl J Med, 307, 329, 10.1056/NEJM198208053070601 · DOI
  28. Taskinen, 1992, Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus, Diabetes, 41, 12, 10.2337/diab.41.2.S12 · DOI
  29. Tatami, 1981, Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease, Circulation, 64, 1174, 10.1161/01.CIR.64.6.1174 · DOI
  30. Steiner, 1987, The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease, Circulation, 75, 124, 10.1161/01.CIR.75.1.124 · DOI
  31. Fielding, 1986, Distribution of apolipoprotein E in the plasma of insulin-dependent and noninsulin-dependent diabetics and its relation to cholesterol net transport, J Lipid Res, 27, 1052, 10.1016/S0022-2275(20)38764-2 · DOI
  32. Fielding, 1982, Promotion of sterol efflux and net transport by apolipoprotein E in lecithin:cholesterol acyltransferase deficiency, Metabolism, 31, 1023, 10.1016/0026-0495(82)90146-9 · DOI
  33. Huang, 1994, A plasma lipoprotein containing only apolipoprotein E and with γ mobility on electrophoresis releases cholesterol from cells, Proc Natl Acad Sci USA, 91, 1834, 10.1073/pnas.91.5.1834 · DOI
  34. Krimbou, 1997, Characterization of human plasma apolipoprotein E-containing lipoproteins in the high density lipoprotein size range: focus on pre-β1-LpE, pre-β2-LpE, and α-LpE, J Lipid Res, 38, 35, 10.1016/S0022-2275(20)37273-4 · DOI · Paper page
  35. McNamara, 1996, Lipoprotein remnant cholesterol and triglyceride values in coronary cases and Framingham controls, Circulation (abstract), 94, I

Cited by

Sorted by citations

Metadata

Authors
Marcoux, C., Tremblay, M., Fredenrich, A., Jacques, H., Krimbou, L., Nakajima, K., Davignon, J., & Cohn, J. S.
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
1998-07
Volume
139
Issue
1
Pages
161-171
ISSN
0021-9150
DOI
10.1016/s0021-9150(98)00042-2
Cited by
45
References
3
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review